Correspondence 0001193125-24-154766 from Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802) (KPTI)
Karyopharm Therapeutics Inc. (KPTI) (CIK 0001503802)
Date: June 5, 2024 · CIK: 0001503802 · Accession: 0001193125-24-154766
AI Filing Summary & Sentiment
File numbers found in text: 333-279833
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 5, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Chris Edwards Re: Karyopharm Therapeutics Inc. Registration Statement on Form S-3 Filed May 30, 2024 File No. 333-279833 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Karyopharm Therapeutics Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 279833), so that it may become effective at 4:30 p.m., Eastern Time, on June 7, 2024, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, KARYOPHARM THERAPEUTICS INC. By: /s/ Michael Mano Name: Michael Mano Title: Senior Vice President, General Counsel and Secretary cc: Jason Kropp, Wilmer Cutler Pickering Hale and Dorr LLP Craig Hilts, Wilmer Cutler Pickering Hale and Dorr LLP